PharmGen Science, Inc. (KRX:004720)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,170.00
+40.00 (0.97%)
Last updated: Dec 5, 2025, 9:18 AM KST

PharmGen Science Market Cap

PharmGen Science has a market cap or net worth of 78.20 billion as of December 5, 2025. Its market cap has decreased by -12.18% in one year.

Market Cap
78.20B
Enterprise Value
83.55B
Revenue
171.66B
Ranking
n/a
PE Ratio
664.15
Stock Price
4,170.00

Market Cap Chart

Since August 31, 1995, PharmGen Science's market cap has increased from 10.89B to 78.20B, an increase of 618.00%. That is a compound annual growth rate of 6.73%.

History

DateMarket Cap% Change
Dec 5, 202578.20B5.43%
Dec 30, 202474.18B-33.39%
Dec 28, 2023111.36B5.58%
Dec 29, 2022105.47B-33.88%
Dec 30, 2021159.51B-3.78%
Dec 30, 2020165.78B123.51%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Samsung Biologics 75.96T
Celltrion 40.11T
ALTEOGEN 24.41T
ABL Bio 10.51T
SK Biopharmaceuticals 10.49T
Yuhan 8,755.13B
LigaChem Biosciences 6,753.15B
Peptron 6,645.44B
Market Cap Rankings